Related Experiment Video
Updated: Aug 7, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
A case of infective endocarditis caused by Kocuria rosea in a non-compromised patient
Tsuyoshi Fujimiya1,2, Yoichi Sato2
1Department of Cardiovascular Surgery, Fukushima Medical University, Fukushima, Japan.
Abstract:
A 79-year-old male with no history of immunodeficiency was transferred to our hospital complaining of shortness of breath and general fatigue. He was diagnosed with recent myocardial infarction and underwent emergent percutaneous coronary intervention. However, the course of congestive heart failure was poor, and he required respiratory support and renal replacement therapy. Kocuria rosea was detected in blood culture obtained on admission, and then a follow-up echocardiogram revealed infective endocarditis. We administered ampicillin-sulbactam and performed urgent operation. The post-operative course was uneventful with 4-week administration of antimicrobial agents.
Learning Objectives:
Infective endocarditis caused by Kocuria rosea may also occur in non-compromised patients although K. rosea infections have been reported only in compromised hosts. This pathogen is sensitive to a variety of antibiotics. We selected ampicillin-sulbactam to treat infective endocarditis based on a sensitivity examination, and the patient's post-operative clinical course was uneventful. Ampicillin-sulbactam may be a useful treatment option.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Rheumatic Heart Disease I: Introduction

